BioticsAI CEO Discusses FDA Approval and Fundraising

Robhy Bustami, CEO of BioticsAI, recently spoke with Isabelle Johannessen on Build Mode about the challenges and strategies involved in building a healthcare-focused AI company. He highlighted the importance of FDA approval in their operations and discussed how the team has remained motivated despite the complexities of regulatory compliance. Bustami's insights reflect the realities of fundraising in a highly regulated industry, emphasizing the need for persistence and innovation. This conversation sheds light on the intersection of AI technology and healthcare regulation, a critical area for future developments.